Novartis gains European Commission approval for Lucentis®
6 June 2011 | By Novartis
The European Commission has granted Novartis a new indication for Lucentis® (ranibizumab)...
List view / Grid view
6 June 2011 | By Novartis
The European Commission has granted Novartis a new indication for Lucentis® (ranibizumab)...
20 May 2011 | By Bristol-Myers Squibb Company
The European Commission has approved ELIQUIS® in the 27 countries of the EU...
5 May 2011 | By Pfizer
Pfizer Inc. announced that Revatio® (sildenafil citrate) has been approved by the European Commission...
21 March 2011 | By Novartis
The European Commission has granted Novartis approval for Gilenya®...
9 March 2011 | By Resolute Communications
XEPLION®, has received approval from the European Commission for the treatment of schizophrenia...
2 March 2011 | By Roche
Avastin in combination with paclitaxel will remain a treatment option for women with metastatic breast cancer in Europe...